1.Clinical research for rehabilitation training combined with modified-acupuncture for joint dysfunction after meniscal suture surgery.
Kaimin LUO ; Tianchen QI ; Zhi HOU ; Na BIAN ; Yuejun ZHAO
Chinese Acupuncture & Moxibustion 2017;37(9):957-960
OBJECTIVETo compare the effects on joint dysfunction after meniscal suture surgery between rehabilitation training combined with modified-acupuncture and simple rehabilitation training.
METHODSSeventy-one patients with meniscal suture surgery were randomized into an observation group (=36) and a control group (=35). Patients in the observation group received modified-acupuncture combined with rehabilitation training. Acupuncture for 8 weeks were at Zutonggu (BL 65), Shugu (BL 66), Neiting (ST 44), Xiangu (ST 43), Xiaxi (GB 43), Zulinqi (GB 41), Dadu (SP 2), Taibai (SP 3), Xingjian (LR 2), and Taichong (LR 3), once a day for continuous 6 days with 1 day for rest. Patients in the control group received simple rehabilitation training for continuous 8 weeks. The training included quadriceps femoris, range of knee joint motion and motion and limb walking on the affected side. The effect score for meniscus injury after treatment from Japanese Orthopaedics Association (JOA) and visual analogue scale (VAS) score were recorded before and after treatment. The effects were compared in the two groups.
RESULTSAfter treatment, the VAS and JOA scores were improved in the two groups (all<0.05), with better results in the observation group (both<0.05). The effective rate was 91.7% (33/36) in the observation group, which was better than 80.0% (28/35) in the control group (<0.05).
CONCLUSIONRehabilitation training combined with-acupuncture achieve better effect than simple rehabilitation training for joint dysfunction after meniscal suture surgery.
2.Clinical analysis of placenta previa complicated with previous caesarean section.
Ma LIANG-KUN ; Na NA ; Yang JIAN-QIU ; Bian XU-MING ; Liu JUN-TAO
Chinese Medical Sciences Journal 2012;27(3):129-133
OBJECTIVETo investigate the clinical features and treatment of placenta previa complicated with previous caesarean section.
METHODSThe clinical data of 29 patients with placenta previa complicated with a previous caesarean section (RCS group) admitted in Peking Union Medical College Hospital during a period from 2003 to 2011 were retrospectively reviewed and compared with those of 243 patients with placenta previa without a previous caesarean section (FCS group) during the same period.
RESULTSThere was no difference in the mean age (28.9±3.6 vs.28.1±4.5 years) and the average gravidity (2.35±1.48 vs.2.21±1.53) between RCS group and FCS group (all P>0.05).The RCS group had more preterm births (24.1% vs.13.2%), complete placenta previa (55.2% vs.4.9%), placenta accreta (34.5% vs.2.5%), more blood loss during caesarean section (1412±602 vs.648±265 mL), blood transfusion (51.7% vs.4.9%), disseminated intravascular coagulation (13.8% vs.2.1%), and obstetric hysterectomy (13.8% vs.0.8%) than the FCS group (all P<0.05).The preterm infant rate (30.0% vs.13.0%), neonatal asphyxia rate (10.0% vs.4.9%), and perinatal mortality rate (6.7% vs.0.4%) of the RCS group were higher than those of the FCS group (all P<0.05).
CONCLUSIONSMore patients had complete placenta previa and placenta accreta, postpartum hemorrhage, transfusion, uterine packing, obstetric hysterectomy, and perinatal morbidity in the placenta previa patients with previous caesarean section.The patient should be informed of the risk and unnecessary first cesarean sections should be avoided.
Adult ; Cesarean Section ; adverse effects ; statistics & numerical data ; Female ; Humans ; Infant, Newborn ; Morbidity ; Placenta Accreta ; therapy ; Placenta Previa ; therapy ; Postpartum Hemorrhage ; etiology ; Pregnancy ; Pregnancy Outcome ; Retrospective Studies
3.Adiponectin up-regulates the expression of T-cadherin in cardiomyocytes injured by hypoxia/reoxygenation.
Min WANG ; Ying-Ru CHAI ; Chuan-Shi XIAO ; Xu-Jing ZHAO ; Na WEI ; Rui BAI ; Yun-Fei BIAN
Acta Physiologica Sinica 2012;64(3):296-302
The aim of the present study was to investigate the effects of adiponectin (APN) on the expression of T-cadherin in cultured Sprague-Dawley (SD) rat cardiomyocytes injured by hypoxia/reoxygenation (H/R). Primary myocardial cells from neonatal rats were obtained by enzymatic digestion. The cells were divided into control group, H/R group and H/R+APN (3, 10, 20 and 30 μg/mL) groups. The H/R group was incubated in anoxic environment (anoxic solution saturated with high concentration N2) for 3 h, and then in the reoxygenation environment (the reoxygenation solution saturated with pure oxygen) for 1 h. The H/R+APN group was pretreated with different concentrations of APN for 24 h prior to the initiation of H/R. The content of lactate dehydrogenase (LDH) was measured by chemistry chromatometry. Cellular apoptosis was analyzed by flow cytometry and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL). The expression of T-cadherin was detected by RT-PCR and Western blotting. The results showed that, compared with control group, the apoptotic rate and release of LDH were significantly increased in the H/R group, whereas the expressions of T-cad mRNA and protein were decreased. Pretreating with APN significantly and dose-dependently decreased apoptotic rate and LDH release, and up-regulated T-cad mRNA and protein level in rat neonatal cardiomyocytes under H/R conditions. These results suggest that APN may protect cardiomyocytes against H/R-induced injury by up-regulating H/R-decreased T-cad expression.
Adiponectin
;
pharmacology
;
Animals
;
Apoptosis
;
Cadherins
;
metabolism
;
Cell Hypoxia
;
L-Lactate Dehydrogenase
;
metabolism
;
Myocytes, Cardiac
;
drug effects
;
metabolism
;
pathology
;
Oxygen
;
adverse effects
;
Rats
;
Rats, Sprague-Dawley
;
Up-Regulation
4.Cytogenetic and clinical analysis of 340 Chinese patients with primary amenorrhea.
Hong YU ; Xun-min BIAN ; Jun-tao LIU ; Na HAO ; Jing ZHOU ; Shan-ying LIU
Chinese Medical Sciences Journal 2011;26(3):163-167
OBJECTIVETo analyze the relationship between karyotypes and clinic features of patients with primary amenorrhea.
METHODSG banding was done for 340 patients with primary amenorrhea to facilitate individual chromosome identification, and if specific staining for certain portions of the chromosome was necessary, C banding was used. The clinical data were recorded by physical examination and ultrasound scanning.
RESULTSKaryotype analysis of the 340 patients revealed that 180 (52.94%) patients had normal female karyotypes and 160 (47.06%) patients had abnormal karyotypes. The abnormal karyotypes included abnormal X chromosome (150 patients), mosaic X-Y chromosome (4 patients), abnormal autosome (5 patients), and X-autosome translocation (1 patient). The main clinical manifestations in patients with primary amenorrhea were primordial or absent uterus (95.9%), invisible secondary sex features (68.8%), little or absent ovary (62.6%), and short stature (30.0%). The incidence of short stature in patients with X chromosome aberration (46%, 69/150) was significangly higher that in patients with 46, XX (9.44%, 17/180) as well as 46, XY (6.67%, 3/45; Chi square = 146.25, P=0.000). All primary amenorrhea patients with deletion or break-point at Xp1 1.1-11.4 were short statures.
CONCLUSIONSOne of the main reasons of primary amenorrhea is choromosome abnormality, especially heterosome abnormality. It implies the need to routinely screen chromosomal anomalies for such patients. There might be relationship between Xp1 1.1-11.4 integrity and height improvement.
Abnormal Karyotype ; Adolescent ; Adult ; Amenorrhea ; genetics ; pathology ; Asian Continental Ancestry Group ; Chromosome Aberrations ; Chromosomes, Human, X ; genetics ; Chromosomes, Human, Y ; genetics ; Female ; Humans ; Karyotype ; Young Adult
5.Clinical observation on diabetic peripheral neuropathy treated with electroacupuncture and acupoint injection.
Ze JIN ; Bian-Fang ZHANG ; Li-Xia SHANG ; Li-Na WANG ; Yu-Lin WANG ; Jing CHEN ; Shan-Shan JIANG
Chinese Acupuncture & Moxibustion 2011;31(7):613-616
OBJECTIVETo compare the differences in the therapeutic effect on diabetic peripheral neuropathy between the combined therapy of electroacupuncture and acupoint injection and the simple acupoint injection.
METHODSUnder the satisfactory control of blood glucose, 60 cases of diabetic peripheral neuropathy were divided randomly into two groups, 30 cases in each one. In electroacupuncture plus acupoint injection group (group A), electroacupuncture and acupoint injection with Methylcobalamin were administered. Penetrating acupuncture was applied from Gongsun (SP 4) to Quanzhong (Extra) and from Yongquan (KI 1) to Taichong (LR 3) mainly. Acupoint injection was administered on Sanyinjiao (SP 6). In acupoint injection group (group B), only acupoint injection with Methylcobalamin was provided on Sanyinjiao (SP 6). After 2 sessions of treatment, the conduction velocity of ulnar nerve and tibial nerve was measured. The scores of Chinese medicine syndrome and diabetic peripheral neuropathy were recorded before and after treatment in two groups.
RESULTSThe effective rates were 90.0% (27/30) and 63.3% (19/30) in group A and group B respectively, presenting significant statistical difference (P < 0.05). After treatment, the motor nerve conduction velocity (MCV) and sensory nerve conduction velocity (SCV) of ulnar nerve and tibial nerve in group A were higher than those in group B (P < 0.05, P < 0.01). After treatment, the score of Chinese medicine syndrome in group A was lower than that in group B (14.36 +/- 1.88 vs 26.58 +/- 3.52, P < 0.01), the score of diabetic peripheral neuropathy in group A was lower than that in group B (12.86 +/- 4.28 vs 17.89 +/- 4.35, P < 0.01).
CONCLUSIONElectroacupuncture and acupoint injection with Methylcobalamin achieve a significant clinical efficacy on diabetic neuropathy and its efficacy is superior to that of simple acupoint injection with Methylcobalamin. This therapy can effectively increase nerve conduction velocity, control and relieve the symptoms of diabetic peripheral neuropathy.
Acupuncture Points ; Adult ; Aged ; Combined Modality Therapy ; Diabetic Neuropathies ; drug therapy ; physiopathology ; therapy ; Electroacupuncture ; Female ; Humans ; Injections ; Male ; Middle Aged ; Tibial Nerve ; physiopathology ; Vitamin B 12 ; administration & dosage ; analogs & derivatives
6.Protective effect of calcium dobesilate against early diabetic nephropathy of rat kidney.
Mei-Juan GAO ; Ming LIU ; Bo LI ; Ming-Long LI ; Li-Xiang BIAN ; Gui-Na YU
Acta Pharmaceutica Sinica 2009;44(2):126-133
The aim of this study is to study the effect of calcium dobesilate on streptozotocin (STZ)-induced early diabetic nephrophathy (DN) in rats. All male Wistar rats were randomly divided into six groups: normal group; DN blank group; calcium dobesilate 75, 150, and 300 mg x kg(-1) groups and perindopril 0.4 mg x kg(-1) group. Blood glucose and the 24 h urinary albumin were measured dynamically during the experiment, after 8 weeks administration, the level of glycosylated hemoglobin (HbA1c) was determined, the expressions of plasminogen activator inhibitor-1 (PAI-1) and matrix metalloprotein-9 (MMP-9) in cortex of kidney were examined with immunohistochemical staining. The endothelin (ET) in plasma and kidney cortex was measured with radioimmunoassay, renal pathomorphism was observed with light and electron microscopes. Calcium dobesilate could decrease the 24 h urinary albumin and ET in plasma and kidney cortex, down-regulate the expression of PAI-1, and up-regulate MMP-9 in kidney. These findings suggested that calcium dobesilate could protect blood vessel endothelium, inhibit kidney fibrous degeneration, ameliorate renal pathological damage, and protect kidney function in many ways.
Albuminuria
;
Animals
;
Blood Glucose
;
metabolism
;
Calcium Dobesilate
;
pharmacology
;
Diabetes Mellitus, Experimental
;
blood
;
metabolism
;
pathology
;
Diabetic Nephropathies
;
blood
;
metabolism
;
pathology
;
Endothelins
;
blood
;
metabolism
;
Glycated Hemoglobin A
;
metabolism
;
Hemostatics
;
pharmacology
;
Kidney Cortex
;
metabolism
;
ultrastructure
;
Male
;
Matrix Metalloproteinase 9
;
metabolism
;
Plasminogen Activator Inhibitor 1
;
metabolism
;
Random Allocation
;
Rats
;
Rats, Wistar
7.Pregnancy outcomes of repeat cesarean section in Peking Union Medical College Hospital.
Liang-Kun MA ; Na LIU ; Xu-Ming BIAN ; Li-Rong TENG ; Hong QI ; Xiao-Ming GONG ; Jun-Tao LIU ; Jian-Qiu YANG
Chinese Medical Sciences Journal 2009;24(3):147-150
OBJECTIVETo evaluate the effect of elective repeat cesarean section on the maternal and neonatal outcomes.
METHODSA retrospective clinic- and hospital-based survey was designed for comparing the maternal and neonatal outcomes of elective repeat cesarean section [RCS group (one previous cesarean section) and MRCS group (two or more previous cesarean sections)] and primary cesarean section (FCS group) at Peking Union Medical College Hospital from January 1998 to December 2007.
RESULTSThe incidence of repeat cesarean section increased from 1.26% to 7.32%. The mean gestational age at delivery in RCS group (38.1+/-1.8 weeks) and MRCS group (37.3+/-2.5 weeks) were significantly shorter than that in FCS group (38.9+/-2.1 weeks, all P<0.01). The incidence of complication was 33.8% and 33.3% in RCS group and MRCS group respectively, and was significantly higher than that in FCS group (7.9%, P<0.05). Dense adhesion (13.5% vs. 0.4%, OR=7.156, 95% CI: 1.7-30.7, P<0.01) and uterine rupture (1.0% vs. 0, P<0.05) were commoner in RCS group compared with FCS group. Neonatal morbidity was similar among three groups (P>0.05).
CONCLUSIONSRepeat cesarean section is associated with more complicated surgery technique and increased frequency of maternal morbidity. However, the incidence of neonatal morbidity is similar to primary cesarean section.
Adult ; Cesarean Section ; adverse effects ; Cesarean Section, Repeat ; adverse effects ; China ; epidemiology ; Female ; Gestational Age ; Humans ; Infant, Newborn ; Postoperative Complications ; epidemiology ; Pregnancy ; Pregnancy Complications ; epidemiology ; Pregnancy Outcome ; Retrospective Studies
8.Analysis of MYH7, MYBPC3 and TNNT2 gene mutations in 10 Chinese pedigrees with familial hypertrophic cardiomyopathy and the correlation between genotype and phenotype.
Wen-ling LIU ; Wen-li XIE ; Da-Yi HU ; Tian-gang ZHU ; Yun-tian LI ; Yi-hong SUN ; Cui-lan LI ; Lei LI ; Tian-chang LI ; Hong BIAN ; Qi-guang TONG ; Song-na YANG ; Rui-yun FAN ; Wei CUI
Chinese Journal of Cardiology 2006;34(3):202-207
OBJECTIVEThe aim of this study was to screen the disease-causing gene mutations and investigate the genotype-phenotype correlation in 10 Chinese pedigrees with familial hypertrophic cardiomyopathy (HCM).
METHODSThere are 91 family members from these 10 pedigrees and 5 members were normal mutated carriers, 23 members were HCM patients (14 male) aged from 1.5 to 73 years old. The functional regions of myosin heavy chain gene (MYH7), cardiac myosin-binding protein C (MYBPC3) and cardiac troponin T gene (TNNT2) were screened with PCR and direct sequencing technique. Clinical information from all patients was also evaluated in regard to the genotype.
RESULTSMutations were found in 5 out of 10 pedigrees. Mutations in MYH7 (Arg663His, Glu924Lys and Ile736Thr) were found in 3 pedigrees and 3 patients from these pedigrees suffered sudden death at age 20-48 years old during sport. Mutations in MYBPC3 were found in 2 pedigrees, 1 with complex mutation (Arg502Trp and splicing mutation IVS27 + 12C > T) and 1 with novel frame shift mutation (Gly347fs) and the latter pedigree has sudden death history. No mutation was identified in TNNT2.
CONCLUSIONSAlthough the Han Chinese is a relatively homogeneous ethnic group, different HCM gene mutations were responsible for familiar HCM suggesting the heterogeneity nature of the disease-causing genes and HCM MYH7 mutations are associated with a higher risk of sudden death in this cohort. Furthermore, identical mutation might result in different phenotypes suggesting that multiple factors might be involved in the pathogenesis of familiar HCM.
Adolescent ; Adult ; Aged ; Asian Continental Ancestry Group ; genetics ; Cardiac Myosins ; genetics ; Cardiomyopathy, Hypertrophic, Familial ; ethnology ; genetics ; Carrier Proteins ; genetics ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Middle Aged ; Mutation ; Myosin Heavy Chains ; genetics ; Pedigree ; Phenotype ; Troponin T ; genetics ; Young Adult
10.Screening by maternal serum markers for Down's syndrome.
Jun-tao LIU ; Na HAO ; Nian-hu SUN ; Feng-yun WANG ; Yun-hua XU ; Ming-ying GAI ; Xu-ming BIAN ; Jian-qiu YANG
Acta Academiae Medicinae Sinicae 2003;25(2):156-159
OBJECTIVETo investigate the optimal method of screening for Down's syndrome (DS) with maternal serum mankers.
METHODSScreening by maternal serum markers for Down's syndrome was offered to all 2886 pregnant women in Peking Union Medical Hospital during 1996.11-2001.3. Alpha-fetoprotein (AFP), human chorionic gonadotrophin (free beta-HCG) were used as markers during the first year of pregnancy. Alpha-fetoprotein, free human chorionic gonadotrophin (HCG) and pregnancy-associated plasma protein A (PAPP-A) were used as mid pregnancy and first-trimester markers in next three years. Amniocentesis and (CVS) were done in those defined as risk cases.
RESULTSThe detection rate of Down's syndrome by maternal serum markers was 3.8% (11/2886). The proportion of false positive results in group of triple markers (alpha FP, free beta-HCG, PAPP-A) was 5%.
CONCLUSIONSThe PAPP-A was a good marker to detect Down's syndrome in early pregnancy and may be used to predict the outcome during mid trimester of pregnancy. The AFP and free beta-HCG can be useful markers to detect Down's syndrome and fetal abnormality. While prenatal diagnostics can be shifted to an early pregnant period.
Adult ; Amniocentesis ; Biomarkers ; blood ; Chorionic Gonadotropin, beta Subunit, Human ; blood ; Down Syndrome ; diagnosis ; prevention & control ; Female ; Fetal Diseases ; diagnosis ; prevention & control ; Humans ; Mass Screening ; Pregnancy ; blood ; Pregnancy-Associated Plasma Protein-A ; analysis ; Prenatal Diagnosis ; methods ; alpha-Fetoproteins ; analysis

Result Analysis
Print
Save
E-mail